Skip to main content
Top
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology 1/2005

01-01-2005 | Clinical Investigation

Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patients

Authors: Hideharu Funatsu, Hidetoshi Yamashita, Hidetaka Noma, Tatsuya Mimura, Shinko Nakamura, Kumi Sakata, Sadao Hori

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 1/2005

Login to get access

Abstract

Background

Cytokine levels are elevated in the ocular fluid of diabetic patients. It is unclear whether aqueous humor levels of vascular endothelial growth factor (VEGF) and interleukin-6 (IL-6) are related to the vitreous fluid levels of these substances and to the progression of diabetic retinopathy.

Methods

Aqueous humor and vitreous fluid samples were obtained during cataract and vitreous surgery from ten eyes of ten patients with diabetic macular edema and 26 eyes of 26 patients with proliferative diabetic retinopathy (PDR). The VEGF and IL-6 levels in aqueous humor, vitreous fluid, and plasma were measured by enzyme-linked immunosorbent assay.

Results

VEGF and IL-6 levels in aqueous humor were significantly correlated with those in vitreous fluid (ρ=0.793 and ρ=0.737, respectively). VEGF levels in aqueous humor and vitreous fluid were significantly correlated with the corresponding IL-6 levels (ρ=0.631 and ρ=0.687, respectively). The aqueous and vitreous levels of VEGF were significantly correlated with the severity of diabetic retinopathy (ρ=0.659 and ρ=0.771, respectively). Aqueous and vitreous levels of IL-6 were also significantly correlated with the severity of diabetic retinopathy (ρ=0.742 and ρ=0.746, respectively). Aqueous and vitreous levels of both VEGF and IL-6 were significantly higher in the patients with active PDR than those in quiescent PDR.

Conclusions

Our results suggest that there is a significant relationship between VEGF and IL-6 levels in aqueous humor and in vitreous fluid. Measurement of the aqueous levels of VEGF and IL-6 may be useful to analyze the pathogenesis of diabetic retinopathy and to predict disease activity.
Literature
1.
go back to reference Abu El Asrar AM, Maimone D, Morse PH et al (1992) Cytokines in the vitreous of patients with proliferative diabetic retinopathy. Am J Ophthalmol 114:731–736PubMed Abu El Asrar AM, Maimone D, Morse PH et al (1992) Cytokines in the vitreous of patients with proliferative diabetic retinopathy. Am J Ophthalmol 114:731–736PubMed
2.
go back to reference Aiello LP, Avery RL, Arrigg PG et al (1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480–1487CrossRefPubMed Aiello LP, Avery RL, Arrigg PG et al (1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480–1487CrossRefPubMed
3.
go back to reference Aiello LP, Bursell SE, Clermont A et al (1997) Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective B-isoform-selective inhibitor. Diabetes 46:1473–1480PubMed Aiello LP, Bursell SE, Clermont A et al (1997) Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective B-isoform-selective inhibitor. Diabetes 46:1473–1480PubMed
4.
go back to reference Burgos R, Simo R, Audi L et al (1997) Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy. Diabetologia 40:1107–1109CrossRefPubMed Burgos R, Simo R, Audi L et al (1997) Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy. Diabetologia 40:1107–1109CrossRefPubMed
5.
go back to reference Cai J, Boulton M (2002) The pathogenesis of diabetic retinopathy. Old concepts and new questions. Eye 16:242–260CrossRefPubMed Cai J, Boulton M (2002) The pathogenesis of diabetic retinopathy. Old concepts and new questions. Eye 16:242–260CrossRefPubMed
6.
go back to reference Chakrbarti S, Cukiernik M, Hleeto D et al (2002) Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy. Diabetes Metab Res Rev 16:393–407CrossRef Chakrbarti S, Cukiernik M, Hleeto D et al (2002) Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy. Diabetes Metab Res Rev 16:393–407CrossRef
7.
go back to reference Cohen T, Nahari D, Cerem LW et al (1996) Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem 271:736–741CrossRefPubMed Cohen T, Nahari D, Cerem LW et al (1996) Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem 271:736–741CrossRefPubMed
8.
go back to reference Cubitt CL, Lausch RN, Oakes JE (1995) Differences in interleukin-6 gene expression between cultured human corneal epithelial cells and keratocytes. Invest Ophthalmol Vis Sci 36:330–336PubMed Cubitt CL, Lausch RN, Oakes JE (1995) Differences in interleukin-6 gene expression between cultured human corneal epithelial cells and keratocytes. Invest Ophthalmol Vis Sci 36:330–336PubMed
9.
go back to reference Early Treatment Diabetic Retinopathy Study Research Group (1985) Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report 1. Arch Ophthalmol 103:1796–1806PubMed Early Treatment Diabetic Retinopathy Study Research Group (1985) Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report 1. Arch Ophthalmol 103:1796–1806PubMed
10.
go back to reference Early Treatment Diabetic Retinopathy Study Research Group (1991) Grading diabetic retinopathy from stereoscopic color fundus photographs. An extension of the modified Airlie House classification. ETDRS Report Number 10. Ophthalmology 98:786–806PubMed Early Treatment Diabetic Retinopathy Study Research Group (1991) Grading diabetic retinopathy from stereoscopic color fundus photographs. An extension of the modified Airlie House classification. ETDRS Report Number 10. Ophthalmology 98:786–806PubMed
11.
go back to reference Early Treatment Diabetic Retinopathy Study Research Group (1991) Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS Report Number 12. Ophthalmology 98:823–833PubMed Early Treatment Diabetic Retinopathy Study Research Group (1991) Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS Report Number 12. Ophthalmology 98:823–833PubMed
12.
go back to reference Elner VM, Scales W, Elner SG et al (1992) Interleukin-6 (IL-6) gene expression and secretion by cytokine-stimulated human retinal epithelium cells. Exp Eye Res 54:361–368CrossRefPubMed Elner VM, Scales W, Elner SG et al (1992) Interleukin-6 (IL-6) gene expression and secretion by cytokine-stimulated human retinal epithelium cells. Exp Eye Res 54:361–368CrossRefPubMed
13.
go back to reference Funatsu H, Yamashita H, Shimizu E et al (2001) Relationship between vascular endothelial growth factor and interleukin-6 in diabetic retinopathy. Retina 21:469–477CrossRefPubMed Funatsu H, Yamashita H, Shimizu E et al (2001) Relationship between vascular endothelial growth factor and interleukin-6 in diabetic retinopathy. Retina 21:469–477CrossRefPubMed
14.
go back to reference Funatsu H, Yamashita H, Noma H et al (2002) Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetic macular edema. Am J Ophthalmol 133:70–77CrossRefPubMed Funatsu H, Yamashita H, Noma H et al (2002) Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetic macular edema. Am J Ophthalmol 133:70–77CrossRefPubMed
15.
go back to reference Katsura Y, Okano T, Noritake M et al (1998) Hepatocyte growth factor in vitreous fluid of patients with proliferative diabetic retinopathy and other retinal disorders. Diabetes Care 21:1759–1763PubMed Katsura Y, Okano T, Noritake M et al (1998) Hepatocyte growth factor in vitreous fluid of patients with proliferative diabetic retinopathy and other retinal disorders. Diabetes Care 21:1759–1763PubMed
16.
go back to reference Lip PL, Belgore F, Blann AD et al (2000) Plasma VEGF and soluble VEGF receptor Flt-1 in proliferative retinopathy: Relationship to endothelial dysfunction and laser treatment. Invest Ophthalmol Vis Sci 41:2115–2119PubMed Lip PL, Belgore F, Blann AD et al (2000) Plasma VEGF and soluble VEGF receptor Flt-1 in proliferative retinopathy: Relationship to endothelial dysfunction and laser treatment. Invest Ophthalmol Vis Sci 41:2115–2119PubMed
17.
go back to reference Lotz M (1995) Interleukin-6. A comprehensive review. Cancer Treat Res 80:209–233PubMed Lotz M (1995) Interleukin-6. A comprehensive review. Cancer Treat Res 80:209–233PubMed
18.
go back to reference Lutty GA, McLeod S, Merges C et al (1996) Localization of vascular endothelial growth factor in human retina and choroid. Arch Ophthalmol 114:971–977PubMed Lutty GA, McLeod S, Merges C et al (1996) Localization of vascular endothelial growth factor in human retina and choroid. Arch Ophthalmol 114:971–977PubMed
19.
go back to reference Maruo N, Morita I, Shirao M, Murota S (1992) IL-6 increases endothelial permeability in vitro. Endocrinology 131:710–714CrossRefPubMed Maruo N, Morita I, Shirao M, Murota S (1992) IL-6 increases endothelial permeability in vitro. Endocrinology 131:710–714CrossRefPubMed
20.
go back to reference Morohoshi M, Fujisawa K, Uchimura I, Numano F (1996) Glucose-dependent interleukin 6 and tumor necrosis factor production by human peripheral blood monocytes in vitro. Diabetes 45:954–959PubMed Morohoshi M, Fujisawa K, Uchimura I, Numano F (1996) Glucose-dependent interleukin 6 and tumor necrosis factor production by human peripheral blood monocytes in vitro. Diabetes 45:954–959PubMed
21.
go back to reference Punglia RS, Lu M, Hsu J et al (1997) Regulation of vascular endothelial growth factor expression by insulin-like growth factor. Diabetes 46:1619–1626PubMed Punglia RS, Lu M, Hsu J et al (1997) Regulation of vascular endothelial growth factor expression by insulin-like growth factor. Diabetes 46:1619–1626PubMed
22.
go back to reference SAS Institute Inc (1997) SAS/STAT Software. Changes and Enhancements through. Release 6.12., Cary, NC, USA, 1–1167 SAS Institute Inc (1997) SAS/STAT Software. Changes and Enhancements through. Release 6.12., Cary, NC, USA, 1–1167
23.
go back to reference Scheiki D, Itin A, Soffer D, Keshet E (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843–845CrossRefPubMed Scheiki D, Itin A, Soffer D, Keshet E (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843–845CrossRefPubMed
24.
go back to reference Yan SF, Tritto I, Pinsky D et al (1995) Induction of interleukin-6 (IL-6) by hypoxia in vascular cells. J Biol Chem 270:11463–11471CrossRefPubMed Yan SF, Tritto I, Pinsky D et al (1995) Induction of interleukin-6 (IL-6) by hypoxia in vascular cells. J Biol Chem 270:11463–11471CrossRefPubMed
Metadata
Title
Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patients
Authors
Hideharu Funatsu
Hidetoshi Yamashita
Hidetaka Noma
Tatsuya Mimura
Shinko Nakamura
Kumi Sakata
Sadao Hori
Publication date
01-01-2005
Publisher
Springer-Verlag
Published in
Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 1/2005
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-004-0950-7

Other articles of this Issue 1/2005

Graefe's Archive for Clinical and Experimental Ophthalmology 1/2005 Go to the issue

Announcements

January 2005